News Release

Botox cousin can reduce malaria in an environmentally friendly way

Peer-Reviewed Publication

Stockholm University

The Structure of the Part of PMP1 that 'Recognizes' the Malaria Mosquito

image: The newly discovered neurotoxin that specifically targets malaria mosquitoes. The structure of the part of PMP1 that 'recognizes' the malaria mosquito. view more 

Credit: Geoffrey Masuyer/Stockholm University

Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitos. This can lead to innovative and environmentally friendly approaches to reduce malaria. The results are presented in an article published in Nature Communications.

Botox (Botulinum neurotoxins) and the toxin causing tetanus belong to the same family of proteins and are among the most toxic substances known. Previously this family of toxins has been believed to only target vertebrates such as humans, mice and birds. But now, researchers have found a toxin which targets the group of mosquitoes that are responsible for transmitting malaria.

"We have discovered a neurotoxin, PMP1, that selectively targets malaria mosquitos, demonstrating that this family of toxins have a much broader host spectrum than previously believed", says Pål Stenmark of Stockholm University and Lund University. He leads the joint research group from the two Swedish universities that has discovered the new neurotoxin in close collaboration with Sarjeet Gill's research group at the University of California.

"PMP1 makes it possible to reduce the prevalence of malaria in a new and environmentally friendly way. Because these toxins are proteins, they do not leave any artificial residues as they decompose. PMP1 may also be developed into biological insecticides designed to target other selected disease vectors or pests", Pål Stenmark says.

Today, insecticides and mosquito nets treated with insecticides are the main means of combating the spread of malaria, but new methods of combating malaria mosquitoes must be developed constantly as mosquitoes become resistant to most toxins over time.

"We found PMP1 in a bacterium from two threatened habitats: a mangrove swamp in Malaysia and the forest floor in Brazil. It shows just how important it is to protect these treasure chests of biological diversity", Pål Stenmark says.

###

The article "A neurotoxin that specifically targets Anopheles mosquitoes" is published in Nature Communications. https://www.nature.com/articles/s41467-019-10732-w

For more information, please contact Pål Stenmark, Department of Biochemistry and Biophysics, Stockholm University, and the Department of Experimental Medical Science, Lund University. Phone: +46 73-984 12 16, e-mail: stenmark@dbb.su.se

Malaria Malaria is one of the most common and serious diseases in the world. It is caused by unicellular parasites which are spread by some mosquitoes. Every year, about half a million people die of the disease, most of them children in Africa. Around 200 million people suffer from malaria. Source: World Health Organization (WHO)


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.